Publication | Closed Access
Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice
90
Citations
33
References
2016
Year
HHcy activates the AHR-CD36 pathway by increasing hepatic LXA4 content, which results in hepatic steatosis. (Hepatology 2016;64:92-105).
| Year | Citations | |
|---|---|---|
Page 1
Page 1